Related Experiment Video
Updated: Feb 27, 2026
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
6.0K
CHI3L1 Expression in Chordoma: Implications for Immunotherapeutic Intervention
Beatrice Campilan1, Christian Godinez1, Jonathan Arditi1
1Department of Neurosurgery, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Cells
|February 26, 2026
Summary
Chitinase-3-like 1 (CHI3L1) shows elevated expression in chordoma tumors, suggesting its potential as a biomarker and therapeutic target for primary chordoma, a rare and aggressive cancer.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Chordomas are rare, aggressive spinal tumors with poor prognoses.
- Current treatments are limited, necessitating new therapeutic targets.
- Chitinase-3-like 1 (CHI3L1) is implicated in immune regulation and tumor progression.
Purpose of the Study:
- To investigate the expression and role of CHI3L1 in chordoma.
- To evaluate CHI3L1 as a potential biomarker and therapeutic target for chordoma.
Main Methods:
- RNA-based analyses were performed on chordoma cell lines and tumor specimens.
- Enzyme-linked immunosorbent assays (ELISA) were used to quantify CHI3L1 levels.
- Expression was compared between chordoma cells, notochordal precursors, and primary versus recurrent tumors.
Main Results:
- CHI3L1 expression is significantly elevated in chordoma cells compared to notochordal precursors.
- Primary chordoma tumors exhibited higher CHI3L1 expression than recurrent tumors.
- These findings indicate CHI3L1's potential involvement in chordoma development.
Conclusions:
- CHI3L1 is a promising biomarker and therapeutic target for primary chordoma.
- Further research is needed to understand CHI3L1's role in immune evasion and develop targeted therapies.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K